Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer

被引：1
|
作者：
Shi, X. [1 ]
Liu, X. [1 ]
Wang, Y. [2 ]
Lu, D. [1 ]
Dong, X. [1 ]
Feng, S. [1 ]
Cai, K. [1 ]
机构：
[1] Nanfang Hosp, Thorac Surg, Guangzhou, Guangdong, Peoples R China
[2] Nanfang Hosp, Oncol, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
small cell lung cancer; survival; Angiogenesis Inhibitors;
D O I：
10.1016/j.jtho.2018.08.1384
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-08
引用
收藏
页码：S793 / S793
页数：1
相关论文
共 50 条
  • [21] Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis
    Peng, Jun
    Liu, Jinfeng
    Liu, Huining
    Huang, Yan
    Ren, Yingchun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [22] Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer patients: A network meta-analysis
    Wu, Ziyang
    Chen, Suhua
    Du, Xin
    Wu, Yibo
    Xie, Xiaohui
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 310 - 318
  • [23] Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
    Kim, Bum Jun
    Kim, Jung Han
    Kim, Hyeong Su
    ONCOTARGET, 2017, 8 (31) : 51779 - 51785
  • [24] MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
    Kim, Jung Han
    Kim, Hyeong Su
    Kim, Bum Jun
    ONCOTARGET, 2017, 8 (43) : 75500 - 75508
  • [25] The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis
    Zhang, Shanshan
    Bi, Minghong
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (06) : 4081 - 4088
  • [26] Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
    Lee, P. W. P.
    Krishnan, N.
    Boldt, G.
    Lakkunarajah, S.
    Blanchette, P.
    Raphael, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1076 - S1076
  • [27] Targeted drugs for unselected patients with advanced non-small-cell lung cancer: a network meta-analysis
    Sheng, Miaomiao
    Zhao, Yueguang
    Wang, Fang
    Li, Shanshan
    Wang, Xiaojie
    Shou, Tao
    Luo, Ying
    Tang, Wenru
    JOURNAL OF THORACIC DISEASE, 2016, 8 (01) : 98 - U383
  • [28] Checkpoint inhibitors in advanced nonsmall-cell lung cancer; a Bayesian network meta-analysis
    Bozcuk, Hakan
    Yildirim, Mustafa
    Sever, Ozlem
    Mutlu, Hasan
    Artac, Mehmet
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 828 - 837
  • [29] Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis
    Raphael, Jacques
    Batra, Anupam
    Boldt, Gabriel
    Shah, Prakesh S.
    Blanchette, Phillip
    Rodrigues, George
    Vincent, Mark D.
    CLINICAL LUNG CANCER, 2020, 21 (02) : 106 - +
  • [30] Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis
    Federico, Alessandro Di
    Giglio, Andrea De
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01): : 29 - 42
12345